[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cvrx Inc (CVRX)

Cvrx Inc (CVRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 162,135
  • Shares Outstanding, K 26,536
  • Annual Sales, $ 56,650 K
  • Annual Income, $ -53,310 K
  • EBIT $ -50 M
  • EBITDA $ -49 M
  • 60-Month Beta 0.90
  • Price/Sales 2.84
  • Price/Cash Flow N/A
  • Price/Book 5.51

Options Overview Details

View History
  • Implied Volatility 221.88% (+75.67%)
  • Historical Volatility 105.13%
  • IV Percentile 80%
  • IV Rank 25.14%
  • IV High 800.99% on 01/20/26
  • IV Low 27.44% on 09/02/25
  • Expected Move (DTE 25) 0.85 (13.91%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 27
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 641
  • Open Int (30-Day) 645
  • Expected Range 5.26 to 6.96

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.52
  • Number of Estimates 3
  • High Estimate $-0.46
  • Low Estimate $-0.57
  • Prior Year $-0.57
  • Growth Rate Est. (year over year) +8.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.00 +22.20%
on 05/13/26
8.19 -25.40%
on 04/23/26
-1.87 (-23.43%)
since 04/22/26
3-Month
5.00 +22.20%
on 05/13/26
9.84 -37.91%
on 03/26/26
unch (unch)
since 02/20/26
52-Week
4.37 +39.81%
on 02/17/26
11.30 -45.93%
on 11/03/25
-0.54 (-8.12%)
since 05/22/25

Most Recent Stories

More News
CVRx to Present at the William Blair 46th Annual Growth Stock Conference

MINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...

CVRX : 6.11 (+0.66%)
CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy

MINNEAPOLIS, May 14, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...

CVRX : 6.11 (+0.66%)
CVRx Q1 Earnings Call Highlights

CVRx (NASDAQ:CVRX) reported first-quarter 2026 revenue of $14.8 million, up 20% from the prior-year period, as U.S. growth in its Barostim heart failure business helped the company exceed the high end...

CVRX : 6.11 (+0.66%)
CVRx: Q1 Earnings Snapshot

CVRx: Q1 Earnings Snapshot

CVRX : 6.11 (+0.66%)
CVRx Reports First Quarter 2026 Financial and Operating Results

MINNEAPOLIS, May 11, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...

CVRX : 6.11 (+0.66%)
CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients...

CVRX : 6.11 (+0.66%)
CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026

MINNEAPOLIS, April 27, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...

CVRX : 6.11 (+0.66%)
CVRx Announces Nomination of Michael Dale for Election to the Board of Directors

MINNEAPOLIS, April 20, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients...

AXGN : 40.90 (-0.99%)
CVRX : 6.11 (+0.66%)
CVRx Reports Preliminary First Quarter 2026 Financial Results

Delivered strong topline performance with first quarter revenue expected to be $14.7 million to $14.8 million, approximately 20% growth compared to first quarter of 2025 Early data in 2026 shows an...

CVRX : 6.11 (+0.66%)
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, continues its investigation on behalf of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX ...

CVRX : 6.11 (+0.66%)

Business Summary

CVRx Inc. is a commercial-stage medical device company. It focused on developing, manufacturing and commercializing neuromodulation solutions for patients with cardiovascular diseases. CVRx Inc. is headquartered in Minneapolis, MN.

See More

Key Turning Points

3rd Resistance Point 6.67
2nd Resistance Point 6.55
1st Resistance Point 6.33
Last Price 6.11
1st Support Level 5.99
2nd Support Level 5.87
3rd Support Level 5.65

See More

52-Week High 11.30
Fibonacci 61.8% 8.65
Fibonacci 50% 7.84
Fibonacci 38.2% 7.02
Last Price 6.11
52-Week Low 4.37

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.